Evidence map›Paper›PMID 40061001›Full record

ArticleActa informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH2024

Population Effect of Croslinking Treatment for Keratoconus in a Pediatric Population.

Bojana Pandurevic, Melisa Ahmedbegovic-Pjano, Senad Grisevic, Nita Bejdic, Ajla Skopljak-Salkica, Ivana Mravicic, Alma Biscevic

Abstract read
In one paragraph

Article in Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Bojana PandurevicEye Clinic Svjetlost, Sarajevo, Bosnia and Herzegovina.
Melisa Ahmedbegovic-PjanoEye Clinic Svjetlost, Sarajevo, Bosnia and Herzegovina.
Senad GrisevicEye Clinic Svjetlost, Sarajevo, Bosnia and Herzegovina.
Nita BejdicEye Clinic Svjetlost, Sarajevo, Bosnia and Herzegovina.
Ajla Skopljak-SalkicaEye Clinic Svjetlost, Sarajevo, Bosnia and Herzegovina.
Ivana MravicicUniversity Eye Hospital Svjetlost, School of Medicine University of Rijeka, Zagreb, Croatia.
Alma BiscevicEye Clinic Svjetlost, Sarajevo, Bosnia and Herzegovina.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Keratoconus is a progressive condition that weakens the cornea and affects vision. Symptoms typically emerge in the second or third decade of life, though rare cases in young children occur. Early diagnosis is crucial to prevent vision deterioration. Objective: The aim of this study was to evaluate the effectiveness of the accelerated crosslinking treatment for keratoconus in the pediatric population. Methods: This prospective study evaluated 20 eyes in 13 patients with keratoconus who underwent accelerated crosslinking procedures at Eye Clinic Svjetlost Sarajevo with a one-year follow-up. Participants aged 12 to 18 had a confirmed keratoconus diagnosis and corneal thickness over 400 microns. Preoperative examinations included visual acuity (LogMAR scale), keratometry measurements, central corneal thickness, and keratoconus grading using the ABCD system on a Pentacam. Results: Postoperative results showed stability and postoperative improvement of uncorrected and corrected visual acuity (P < 0.001). Postoperative keratometries, specifically Km and Kmax, showed a statistically significant decrease, flattening by approximately 1 diopter (D) and 1.5 diopters (D), respectively. Results of postoperative ABCD score showed stability, without postoperative deviation from the mean value and standard deviation. Central corneal thickness values decreased to 456.48 ± 27.2 μm at the one-year examination, and were statisticaly significant compared to preoperative values (P < 0.001). Conslusion: Stopping progression with crosslinking is the single most important part of management of the pediatric keratoconus patient, thus early diagnosis is imperative. Crosslinking is a safe procedure and the only treatment for pediatric keratoconus that has been proven to halt the progression of the disease and prevent prolonged reduction in a child's visual acuity.

Indexed as

accelerated crosslinkingkeratoconuspediatric population

Identifiers

PMID40061001
PMCPMC11889427

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.